chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient got her first covid shot and then got pneumonia; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). Other Case identifier(s): NVSC2021US292846 _S.  A 70 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PNEUMONIA (medically significant), outcome "unknown", described as "Patient got her first covid shot and then got pneumonia".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a Licensed Vocational Nurse referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not provided. On an unknown date, the patient was vaccinated with the improperly stored dose of ROTATEQ (orally, lot # K016261, expiration date on 23-JUN-2016; dose was not reported). No adverse events were reported. Administered doses of vaccines experienced the temperature excursion of 34 degrees Fahrenheit for 7 days. Data logger was involved. There were no previous excursions reported. This is one of two reports received from the same source. Additional information has been requested.
I was dianosed with necrotizing myopathy on May 28, 2021 I have not received any treatment yet as of 07/01/2021  I had not prior illnesses until I received the covid vaccine.
On 4/13/2022, I took a home test for COVID, and the result was positive. I don't consider my illness severe. I had a very mild headache and was slightly lightheaded. Early on, I had a cough. I also had mild body aches and was very tired. I consulted with my PCP through telehealth on 4/13/2022, and I was prescribed Zyrtec, which I was to take once a day for 30 days. I took another home test on 4/18/2022, and this yielded a positive result. I tested positive again on 4/21/2022. Aside from being confined to my home, I haven't been impeded in my ability to go about my normal activities.
They intended to vaccinate this patient with PNEUMOVAX 23, however she was mistakenly given PREVNAR 20; No additional AE details available / No additional AE reported; This spontaneous report was received from a nurse and refers to a 14-year-old female patient.  The patient's medical history and concomitant therapies were not reported.  The patient qualified to receive pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) as she was at high risk for pneumococcal disease due to pulmonary disease. On an unspecified date, it was intended to vaccinate this patient with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), however, she was mistakenly vaccinated with pneumococcal vaccine conj 20v (CRM197) (PREVNAR 20) instead (strength, dose description, lot #, expiry date, and route of administration were not provided) (wrong product administered). No additional adverse events were reported.
This spontaneous report was received from a pharmacist referring to an unspecified number of patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On an unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot#, dose, route of administration and frequency were unspecified) for prophylaxis. No adverse effects were reported. The vaccines were exposed to a temperature of 47-77 Fahrenheit degrees for a time frame of 9 hours, and there was a previous exposure at the same temperature for a time frame of 16 hours. There was no a digital data logger involved. No product quality complaint was involved. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1706USA002759:
nuclear Stress test; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (nuclear Stress test) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (nuclear Stress test). At the time of the report, VACCINATION COMPLICATION (nuclear Stress test) outcome was unknown.            No concomitant medications were reported.  It was reported that, the patient had nuclear Stress test scheduled a week after 2nd dose. She stated, they would be injecting something to her.  No treatment information was reported.
I got a really bad headache the first day. It progressed to a sore throat and congestion. Four days later I visited a clinic and I tested positive for COVID-19 on 09/30/2021. I was told to rest and drink plenty of fluids. I have a lot of fatigue and I couldn't do much. I lost my sense of smell and taste on the seventh day and I still can't smell anything after 8 days. The coughing and congestion got worse but the scratchy throat was only at the start. My family has not gotten sick so far. I have been coughing and I have some chest congestion.
the patient had the vaccine at 0800 at approx 0930 he became very hot and flush.  He reported to the clinic at 0945 and was extremely flushing and shaking only on his left side.  He is immediately given Dexamethasone 10mg and Benadryl 50mg IM.  He was asymptomatic at 1100 hours.
27MAR97 neck swollen w/rash;told to bring for dx larger than fifty cent piece;rx DPH & ATB could not sleep;
01/01/2022:  46-year-old male who denies medical history presents to the emergency department for chest pain, high heart rate. he notes mild dyspnea and states he feels somewhat lightheaded.  denies fevers, body aches, chills, cough but he does state that he is to sons have recently been diagnosed with Covid.  Denies vomiting or diarrhea.  Denies abdominal pain.  COVID exposure
10/26/22 pt had positive COVID test at a local healthcare facility; The PA was the ordering provider; 10/29/22 pt's husband noticed pt with increase labor of breathing; gurgling respirations; EMS called; pulseless; CPR; intubated; in ED CPR was done without ROSC achieved; pt passed away in the local Medical Center ED
fatigue, headache, nausea, body aches, chills/convulsions, fever, soaring heart rate (120 at rest)
pain at the back of her neck; blurry vision; legs are very heavy and uncontrollable; took her 1.5 hours to get up from bed (9:30- 10:45am).; to use her walker which she normally does not.; She has to pick them up and put them them  they did not go where they were supposed to.; dizziness; Injection site was burning, burning; Nausea; Pain at the base of her skull across her shoulders; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (pain at the back of her neck), VISION BLURRED (blurry vision), LIMB DISCOMFORT (legs are very heavy and uncontrollable), SOMNOLENCE (took her 1.5 hours to get up from bed (9:30- 10:45am).) and WALKING AID USER (to use her walker which she normally does not.) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A, 005C21A and 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Parkinsonism and Bladder disorder NOS (has to get up whole night a lot because she has weak bladder).   On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2022, the patient experienced NECK PAIN (pain at the back of her neck), VISION BLURRED (blurry vision), LIMB DISCOMFORT (legs are very heavy and uncontrollable), SOMNOLENCE (took her 1.5 hours to get up from bed (9:30- 10:45am).), WALKING AID USER (to use her walker which she normally does not.), MOVEMENT DISORDER (She has to pick them up and put them them  they did not go where they were supposed to.), DIZZINESS (dizziness), VACCINATION SITE PAIN (Injection site was burning, burning), NAUSEA (Nausea) and ARTHRALGIA (Pain at the base of her skull across her shoulders). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Vaccination site burning, at an unspecified dose and frequency. At the time of the report, NECK PAIN (pain at the back of her neck), VISION BLURRED (blurry vision), LIMB DISCOMFORT (legs are very heavy and uncontrollable), SOMNOLENCE (took her 1.5 hours to get up from bed (9:30- 10:45am).), WALKING AID USER (to use her walker which she normally does not.), MOVEMENT DISORDER (She has to pick them up and put them them  they did not go where they were supposed to.), DIZZINESS (dizziness), VACCINATION SITE PAIN (Injection site was burning, burning), NAUSEA (Nausea) and ARTHRALGIA (Pain at the base of her skull across her shoulders) outcome was unknown.            Concomitant medications were not provided by the reporter.
Axillary lymph node enlargement in the vaccination arm.; Rash over abdomen and lower back; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 12Oct2021 13:30 (Lot number: 1358A) at the age of 64 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Factor 5 Leiden" (unspecified if ongoing), notes: Other medical history:Factor 5 Leiden. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Lot number: ER8733, Administration date: 12Apr2021,10:00AM, Dose number: 2, Vaccine location: Left arm), administration date: 12Apr2021, when the patient was 63 years old, for COVID-19 immunization; Bnt162b2 (Lot number: EN6200, Administration date: 2Mar2021,01:00 PM, Dose number: 1, Vaccine location: Left arm), administration date: 22Mar2021, when the patient was 63 years old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 13Oct2021 07:00, outcome "unknown", described as "Axillary lymph node enlargement in the vaccination arm."; RASH (non-serious) with onset 13Oct2021 07:00, outcome "unknown", described as "Rash over abdomen and lower back". Therapeutic measures were not taken as a result of lymphadenopathy, rash.  Additional information: The patient took vaccine at a Pharmacy or Drug Store. The patient had not received any other vaccine in four weeks and no other medications in two weeks. Prior to vaccination, the patient was not diagnosed with COVID. Since the vaccination, the patient had not been tested for COVID-19 and not having any Known allergies.  No follow-up attempts are possible. No further information is expected.  Follow-up (28Oct2021): Follow-up attempts are completed. No further information is expected.
received his first dose of the series "back around February or end of March/then got COVID19; got COVID19 "without going anywhere; had shortness of breath with palpitations; had shortness of breath with palpitations; This is a spontaneous report from a contactable consumer (Mother). A 33-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on an unspecified date 2021 as DOSE 1, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient received his first dose of the series "back around February or end of March." The family then got COVID19 "without going anywhere." After having the virus, he had shortness of breath with palpitations before he had the chance to get the 2nd dose of the COVID19 vaccine.Her son got the 2nd dose of the vaccine 22Jun2021 after the pharmacy advised him, he did not need to re start the vaccine series. Since having the 2nd dose, he has had achy arms, palpitations, shortness of breath, and chest heaviness. The patient underwent lab tests and procedures which included COVID-19: positive on an unspecified date. The outcome of events was unknown.  information about lot/batch number has been requested.
Pain for a few days in upper left leg in back and then in front, now it stopped  Pain in upper left back, below shoulder, for at least 5 days.  Pulsations in left side of back - almost on my side, at night and during the day.
This spontaneous medically confirmed report (initial receipt 23-Oct-2012) concerns a 63 year old male patient with a medical history of diabetes and hypercholesterolaemia. Concomitant medications include pioglitazone, glimiperide, Calcium with vitamin D, desloratadine, metformin and simvastatin. There were no allergies. On 09-Oct-2012, the patient received an unspecified flu vaccine (manufacturer and batch number unknown). The patient also received a second dose of co-suspect drug 'Sylatron Kit 296/1.25' (peginterferon alpha 2B) on 12-Oct-2012 for melanoma. A dose of SYLATRON was administered subcutaneously with a dose (296 mcg) taken once weekly. The patient started SYLATRON on 05-Oct-2012 (5 days prior to receiving the flu vaccine). On 14-Oct-2012, 6 days after receiving the flu vaccine, the patient developed a diffuse, red, raised rash. On this day the patient presented to the emergency room with a diffuse rash on his trunk and arms. He was prescribed a tapering dose of oral prednisone and completed the course on 19-Oct-2012. On 19-Oct-2012, the patient advised to use topical hydrocortisone cream and promethazine. On 22-Oct-2012 (14 days following flu vaccination), the patient's rash was worse. He had a fever of 103.5 Fahrenheit, a heart rate of 120 and the rash had progressed to cover his neck, lower extremities and back. He was admitted to hospital with a diagnosis of possible shingles. The patient outcome is not yet recovered at the time of reporting.
I have existing non-stop Tinnitus in my left ear and occasional quieter tinnitus in the right ear. The day after the vaccine the volume in the left ear more than doubled to the point it is so loud I am having a hard time hearing conversations. The right ear which before the vaccine only occasionally had tinnitus has it now nearly constantly. The volume has not subsided and I am very concerned that this could be a permanent problem.Where before the tinnitus was live able, this is awful and makes it hard to hear and understand. I don't know what to do about a second dose, if this stays at this level or gets worse it will be intolerable.
After my second vaccination, the next morning I had generalized arthralgias.  The second morning, I woke up with severe, sharp pain in my lower back.   Over the past many weeks, it has begun to improve as I am moving around during the day.
Patient complained of a temporal headache and fatigue beginning day after immunization and continuing daily since that date.  She has taken Tylenol and green tea with some relief.  She also has purposefully rested more often as treatment.  As of 08/30/2005 the patient states that she has an additional symptoms of nasal congestion.  She sought medical care and had blood work done.  She reports that her symptoms gradually went away and that as of 11/07/2005 there was a complete resolution of symptoms.
Diarrhea; vomiting; insomnia; muscle aches/ all over body pain 5 days; muscle aches/ all over body pain 5 days; kidney and bladder cramping pain 2 days; kidney and bladder cramping pain 2 days; chills; low grade fever 101; headaches; Dose Number 1(19Apr2021); Dose Number 2 (03May2021); This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: 2W0175 or ZL0175) via unspecified route in right arm single dos for COVID-19 immunization on 03May2021 18:15, at 38-year-old. The patient medical history was not reported. Concomitant medications included echinacea angustifolia root, echinacea purpurea root, hydrastis canadensis root (ECHINACEA & GOLDENSEAL); herbal nos, minerals nos, vitamins nos (WOMENS ULTRA MEGA). The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: ER8730) in right arm for COVID-19 immunization on 19Apr2021 18:15, at 38-year-old; codeine and experienced allergies. The patient had diarrhea 72 hours, vomiting 6 hours, insomnia 4 days, muscle aches/ all over body pain 5 days, kidney and bladder cramping pain 2 days, chills 2 days, low grade fever 101- 6 hours, headaches more than 6 days; all were on 03May2021 20:00, resulted in doctor or other healthcare professional office/clinic visit, with outcome of recovering after receiving treatment (palliative care, over the counter remedies). Outcome of the other event was unknown.  No follow-up attempts are possible. No further information is expected.
shortness of breath Narrative: Patient experienced some mild shortness of breath while sitting in the post-vaccine observation area. BP 129/83, O2 100% on RA, 81 bpm heart rate. Mild SOB disappeared after about 1-2 minutes. Patient then reported no S/S.
Mild dizziness; Nausea; Mild flu like symptoms; Heightened temperature; Headache; This spontaneous case was reported by an other and describes the occurrence of INFLUENZA LIKE ILLNESS (Mild flu like symptoms), DIZZINESS (Mild dizziness), PYREXIA (Heightened temperature), HEADACHE (Headache) and NAUSEA (Nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced INFLUENZA LIKE ILLNESS (Mild flu like symptoms), PYREXIA (Heightened temperature) and HEADACHE (Headache). On 02-Feb-2021, the patient experienced DIZZINESS (Mild dizziness) and NAUSEA (Nausea). On 03-Feb-2021, INFLUENZA LIKE ILLNESS (Mild flu like symptoms), DIZZINESS (Mild dizziness), PYREXIA (Heightened temperature), HEADACHE (Headache) and NAUSEA (Nausea) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 01-Feb-2021, Body temperature: high (High) heightened temperature.         Action taken with mRNA-1273 in response to the events was not Applicable.  Concomitant product use was not provided by the reporter.  Patient was treated with standard OTC medication.
Developed shortness of breath, cough, pleuritic chest pain with 24-48 hours of second dose. Presented to hospital for evaluation when symptoms didn't resolve with Motrin
Dry heaves; Chills; Body aches; Fever; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of RETCHING (Dry heaves), CHILLS (Chills), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headaches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Chemotherapy. Concurrent medical conditions included Cancer (NOS) since 2021.    On 15-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2022, the patient experienced RETCHING (Dry heaves), CHILLS (Chills), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headaches). On 17-Apr-2022, RETCHING (Dry heaves), CHILLS (Chills), MYALGIA (Body aches), PYREXIA (Fever) and HEADACHE (Headaches) had resolved.            Patient is currently on immunoglobulin treatments which he receives weekly or biweekly and these treatments were needed due to side effects from chemotherapy.  Patient did not experience any adverse evet to the first 3 shots.  Patient experienced the events from  15 Apr 2022 afternoon until 17 Apr 2022 morning- about 36 hours. On 17 Apr 2022 he felt a little out of it and was back to normal by Sunday evening around 6 pm.  No treatment information was reported.
Chicken pox 10-12 spots, most on face and back 6 days until scabbed over.
Significant malaise, shortness of breath, headache, fevers, chills, and midsternal chest pain
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Celiac disease" (unspecified if ongoing); "bariatric surgery" (unspecified if ongoing); "resolved hypertension" (unspecified if ongoing); "OSA" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; FLONASE [MOMETASONE FUROATE]; IRON. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: Paxlovid rebound. Symptoms came back and testing become positive. Therapeutic measures were taken as a result of  covid-19.  Clinical course: Patient received Paxlovid Anti-viral COVID 19 Treatment which start date was 15Jul2022 and stop date was 20Jul2022.  No follow-up attempts are possible, information about batch number cannot be obtained.
12hr of crying/somnolence-emesis x 2, not bilious, dec po intake; no fever; in clinic guaiac positive stool, rt abd mass; intussusception-reduced air enema; adm for observation;
This spontaneous report as received from a 50 year old female consumer refers to a her husband of unknown age. In July 2013 the patient's wife was vaccinated with a dose of ZOSTAVAX (lot number, dose number, dose and route were not reported). There was no concomitant medication of his wife. His wife had a pertinent medical history of skin nervous disorder and with no drug reactions or allergies. His wife called in to report that one month later, her husband developed a case of Shingles. No further AE information was provided. Outcome of the events was unknown. Additional information has been requested.
On 17OCT AM cried often would startle, cry & appear to gasp & hold breath; Did not sleep all day; Took to MD who told mom "probably shots caused", but prescribe nothing; pt leg swollen & red; ER advised ice & Vicks to leg; pt vomited;